MedPath
FDA Approval

MYLERAN

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
May 15, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Busulfan(2 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MYLERAN

Product Details

NDC Product Code
80725-620
Application Number
NDA009386
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
May 15, 2023
BusulfanActive
Code: G1LN9045DKClass: ACTIBQuantity: 2 mg in 1 1
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
TRIACETINInactive
Code: XHX3C3X673Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
© Copyright 2025. All Rights Reserved by MedPath